Rhys G Morgan

9PUBLICATIONS
49CO-AUTHORS
Haematological tumoursPsychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 09, 2026
RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

|May 29, 2026
LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia.

|Jun 25, 2025
Post-transcriptional control of gene expression by β-catenin: expanding the non-canonical ARMoury.

O Sevim, H Park, R G Morgan

|Apr 29, 2025
β-Catenin interacts with canonical RBPs including MSI2 to associate with a Wnt signalling mRNA network in myeloid leukaemia cells.

M Wagstaff, O Sevim, A Goff

|Mar 30, 2022
Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives.

Megan Wagstaff, Brandon Coke, Georgia R Hodgkiss

|Aug 23, 2019
Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells.

Juan Bautista Menendez-Gonzalez, Samantha Sinnadurai, Alex Gibbs

Pageof 2

Frequent Collaborators

3 joint publications

Megan Wagstaff

3 joint publications

Okan Sevim

3 joint publications

Timothy Chevassut

2 joint publications

David A Palmer